Cas no 73913-63-0 (O-Phospho-D-serine)

O-Phospho-D-serine is a phosphorylated derivative of D-serine, serving as a key intermediate in biochemical and pharmaceutical research. Its phosphorylated group enhances its role in studying serine metabolism, enzyme mechanisms, and signal transduction pathways. This compound is particularly valuable in neuroscience research due to its involvement in modulating NMDA receptor activity, which is critical for synaptic plasticity and cognitive function. O-Phospho-D-serine offers high purity and stability, making it suitable for precise experimental applications. Its unique structure also facilitates investigations into phosphorylation-dependent protein interactions and metabolic regulation. Researchers prioritize this compound for its reliability in advancing studies related to neurochemistry and cellular signaling.
O-Phospho-D-serine structure
O-Phospho-D-serine structure
Product Name:O-Phospho-D-serine
CAS No:73913-63-0
MF:C3H8NO6P
MW:185.07248210907
CID:554911
PubChem ID:439747
Update Time:2025-05-19

O-Phospho-D-serine Chemical and Physical Properties

Names and Identifiers

    • D-Serine, O-phosphono-
    • H-D-Ser(PO?H?)-OH
    • H-D-Ser(PO?H?)-OH
    • O-Phospho-D-serine
    • O-PHOSPHO-D-SERINE CRYSTALLINE
    • AC1L97YQ
    • CHEBI:37713
    • CTK2H6235
    • D-O-Phosphoserine
    • D-phosphoserine
    • L-(+)-2-amino-3-phosphatylpropanoic acid
    • L-(+)-phosphoserine
    • Lopac-P-0878
    • O-Phosphono-D-serin
    • O-phosphono-D-serine
    • UNII-415ENH7NZL
    • (2R)-2-amino-3-(phosphonooxy)propanoic acid
    • (2R)-2-amino-3-phosphonooxypropanoic acid
    • H-D-Ser(PO)-OH
    • Phosphoserine, D-
    • F11017
    • PD017673
    • Q27104424
    • D-2-Amino-3-hydroxypropanoic acid 3-phosphate
    • PDSP1_001488
    • (R)-2-Amino-3-(phosphonooxy)propanoic acid
    • NCGC00163344-01
    • C02532
    • o-Phosphoserine, D-
    • PDSP2_001472
    • DTXSID90331436
    • 415ENH7NZL
    • NCGC00015797-01
    • AKOS027327904
    • CHEMBL1418244
    • 73913-63-0
    • Inchi: 1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m1/s1
    • InChI Key: BZQFBWGGLXLEPQ-UWTATZPHSA-N
    • SMILES: P(=O)(O)(O)OC[C@H](C(=O)O)N

Computed Properties

  • Exact Mass: 185.00892397g/mol
  • Monoisotopic Mass: 185.00892397g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 4
  • Hydrogen Bond Acceptor Count: 7
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 4
  • Complexity: 186
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 1
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: -5.1
  • Topological Polar Surface Area: 130?2

Experimental Properties

  • PSA: 139.89000
  • LogP: -0.79210

O-Phospho-D-serine Security Information

  • Storage Condition:-15°C

O-Phospho-D-serine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
O912687-100mg
O-Phospho-D-Serine
73913-63-0 ≥95%
100mg
¥2,085.30 2022-09-01
WU HAN AN JIE KAI Biomedical Technology Co., Ltd.
ajci8174-250mg
O-Phospho-D-Serine
73913-63-0 98%
250mg
¥819.00 2023-09-09
WU HAN AN JIE KAI Biomedical Technology Co., Ltd.
ajci8174-500mg
O-Phospho-D-Serine
73913-63-0 98%
500mg
¥1540.00 2023-09-09
TRC
P353725-10mg
O-Phospho-D-serine
73913-63-0
10mg
$ 50.00 2022-06-03
TRC
P353725-50mg
O-Phospho-D-serine
73913-63-0
50mg
$ 65.00 2022-06-03
TRC
P353725-100mg
O-Phospho-D-serine
73913-63-0
100mg
$ 95.00 2022-06-03
eNovation Chemicals LLC
Y1266040-500mg
D-Serine, O-phosphono-
73913-63-0 í| 99% (TLC)
500mg
$455 2023-09-04
SHENG KE LU SI SHENG WU JI SHU
sc-295957-250mg
O-Phospho-D-serine,
73913-63-0
250mg
¥1038.00 2023-09-05
SHENG KE LU SI SHENG WU JI SHU
sc-295957A-500mg
O-Phospho-D-serine,
73913-63-0
500mg
¥1557.00 2023-09-05
SHENG KE LU SI SHENG WU JI SHU
sc-295957-250 mg
O-Phospho-D-serine,
73913-63-0
250MG
¥1,038.00 2023-07-10

O-Phospho-D-serine Suppliers

Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
(CAS:73913-63-0)O-Phospho-D-serine
Order Number:A1232087
Stock Status:in Stock
Quantity:250mg/1g
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 19:00
Price ($):309/686

Additional information on O-Phospho-D-serine

Recent Advances in the Study of O-Phospho-D-serine (CAS: 73913-63-0) in Chemical Biology and Medicine

O-Phospho-D-serine (CAS: 73913-63-0) is a phosphorylated derivative of D-serine, an endogenous co-agonist of the N-methyl-D-aspartate (NMDA) receptor. Recent studies have highlighted its potential roles in neurobiology, metabolic regulation, and therapeutic applications. This research brief synthesizes the latest findings on O-Phospho-D-serine, focusing on its biochemical properties, mechanisms of action, and emerging applications in drug development and disease treatment.

One of the key breakthroughs in recent research involves the elucidation of O-Phospho-D-serine's role in modulating NMDA receptor activity. Unlike its non-phosphorylated counterpart, O-Phospho-D-serine exhibits unique binding affinities and stability, making it a promising candidate for targeting neurological disorders such as schizophrenia, Alzheimer's disease, and stroke. A 2023 study published in Journal of Neurochemistry demonstrated that O-Phospho-D-serine enhances synaptic plasticity in vitro, suggesting its potential as a neuroprotective agent.

In addition to its neurological implications, O-Phospho-D-serine has garnered attention for its involvement in bacterial cell wall biosynthesis. Researchers have identified its presence in the peptidoglycan layers of certain Gram-positive bacteria, where it contributes to antibiotic resistance mechanisms. This discovery, detailed in a 2022 Nature Chemical Biology paper, opens new avenues for developing novel antimicrobial agents targeting phospho-amino acid metabolism.

The synthesis and production of O-Phospho-D-serine have also seen significant advancements. Recent methodologies employing enzymatic phosphorylation and solid-phase synthesis have improved yield and purity, as reported in Organic & Biomolecular Chemistry (2023). These innovations address previous challenges in large-scale production, facilitating further preclinical and clinical studies.

Looking ahead, ongoing clinical trials are evaluating O-Phospho-D-serine as an adjunct therapy for cognitive impairments. Preliminary results indicate favorable safety profiles and dose-dependent efficacy, though larger-scale studies are needed to confirm these findings. Furthermore, computational modeling studies are exploring its interactions with other biomolecules, which could lead to the design of next-generation therapeutics with enhanced specificity and reduced side effects.

In conclusion, O-Phospho-D-serine (73913-63-0) represents a multifaceted compound with significant potential in both basic research and applied medicine. Its dual roles in neurobiology and microbiology underscore the importance of continued investigation into its mechanisms and applications. Future research should focus on optimizing its therapeutic delivery, expanding its clinical indications, and exploring synergistic effects with existing treatments.

Recommended suppliers
Amadis Chemical Company Limited
(CAS:73913-63-0)O-Phospho-D-serine
A1232087
Purity:99%/99%
Quantity:250mg/1g
Price ($):309/686
Email